Segment Information

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Segment Information

Segment Information

The Company has identified two operating segments, diagnostic services and consumer products, based on the manner in which the Company’s CEO, as Chief Operating Decision Maker, assesses performance and allocates resources across the organization. The operating segments are organized in a manner that depicts the difference in revenue generating synergies that include the separate processes, profit generation and growth of each segment. The diagnostic services segment provides diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. The unallocated corporate expenses mainly included professional fees associated with the public company.

The following table is a summary of segment information for three months ended March 31, 2025 and 2024 (amounts in thousands):

	For the three months ended
	March 31, 2025		March 31, 2024
Net revenues
Diagnostic services	$	—	$	—
Consumer products	1,431		2,356
Consolidated net revenue	1,431		2,356
Cost of revenue
Diagnostic services	232		720
Consumer products	673		1,696
Consolidated cost of revenue	905		2,416
Depreciation and amortization expense
Diagnostic services	334		801
Consumer products	807		804
Total Depreciation and amortization expense	1,141		1,605
Operating and other expenses
Diagnostic services	168		1,824
Consumer products	1,061		1,115
Unallocated corporate	2,834		3,486
Total operating and other expenses	4,063		6,425
Income (loss) from operations, before income taxes
Diagnostic services	(734)		(3,345)
Consumer products	(1,110)		(1,259)
Unallocated corporate	(2,834)		(3,486)
Total loss from operations, before income taxes	(4,678)		(8,090)
Income tax (expense) benefit	—		2,566
Total loss from operations, after income taxes	(4,678)		(5,524)
Net loss from continuing operations	$	(4,678)	$	(5,524)

The following table is a summary of segment information as of March 31, 2025 and December 31, 2024 (amounts in thousands):

	March 31, 2025		December 31, 2024
ASSETS
Diagnostic services	$	25,516	$	26,069
Consumer products	18,712		19,745
Unallocated corporate	5,883		5,804
Assets in discontinued operations	—		11,582
Total assets	$	50,111	$	63,200